| Literature DB >> 19517012 |
Popchai Ngamskulrungroj1, Felix Gilgado, Josiane Faganello, Anastasia P Litvintseva, Ana Lusia Leal, Kin Ming Tsui, Thomas G Mitchell, Marilene Henning Vainstein, Wieland Meyer.
Abstract
The Cryptococcus species complex contains two sibling taxa, Cryptococcus neoformans and Cryptococcus gattii. Both species are basidiomycetous yeasts and major pathogens of humans and other mammals. Genotyping methods have identified major haploid molecular types of C. neoformans (VNI, VNII, VNB and VNIV) and of C. gattii (VGI, VGII, VGIII and VGIV). To investigate the phylogenetic relationships among these haploid genotypes, we selected 73 strains from 2000 globally collected isolates investigated in our previous typing studies, representing each of these genotypes and carried out multigene sequence analyses using four genetically unlinked nuclear loci, ACT1, IDE, PLB1 and URA5. The separate or combined sequence analyses of all four loci revealed seven clades with significant support for each molecular type. However, three strains of each species revealed some incongruence between the original molecular type and the sequence-based type obtained here. The topology of the individual gene trees was identical for each clade of C. neoformans but incongruent for the clades of C. gattii indicating recent recombination events within C. gattii. There was strong evidence of recombination in the global VGII population. Both parsimony and likelihood analyses supported three major clades of C. neoformans (VNI/VNB, VNII and VNIV) and four major clades of C. gattii (VGI, VGII, VGIII and VGIV). The sequence variation between VGI, VGIII and VGIV was similar to that between VNI/VNB and VNII. MATa was for the first time identified for VGIV. The VNIV and VGII clades are basal to the C. neoformans or the C. gattii clade, respectively. Divergence times among the seven haploid monophyletic lineages in the Cryptococcus species complex were estimated by applying the hypothesis of the molecular clock. The genetic variation found among all of these haploid monophyletic lineages indicates that they warrant varietal status.Entities:
Mesh:
Year: 2009 PMID: 19517012 PMCID: PMC2690690 DOI: 10.1371/journal.pone.0005862
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of strains used in this study, including general strain information, serotype (ST), mating type (MAT), molecular type (MT) and the allele assignment for the four genes used in the multigene analysis.
| Isolates | WM No. | Country | Source | ST | MAT | MT | References | Allele Assignment | |||
|
|
|
|
| ||||||||
|
| |||||||||||
| ATCC 90112 | WM 419 | USA | CLIN | A | alpha | VNI |
| 1 | 1 | 1 | 1 |
| M27049 | WM 2573 | South Africa | CLIN | - | alpha | VNI | This study | 2 | 1 | 2 | 1 |
| WM 721 | WM 721 | India | ENV | A | alpha | VNI | This study | 3 | 1 | 2 | 1 |
| WM 148R | WM 148 | Australia | CLIN | A | alpha | VNI |
| 3 | 2 | 16 | 1 |
| RV 59369 | WM 1416 | Belgium | ENV | A | alpha | VNI | This study | 1 | 1 | 1 | 2 |
| NIH 193 | WM 1421 | USA | ENV | A | alpha | VNI | This study | 2 | 1 | 1 | 1 |
| LA 26 | WM 1641 | Mexico | ENV | A | alpha | VNI |
| 2 | 3 | 15 | 1 |
| LA 182 | WM 1897 | Spain | CLIN | A | alpha | VNI |
| 2 | 1 | 15 | 1 |
| LA 264 | WM 1742 | Chile | CLIN | A | alpha | VNI |
| 2 | 1 | 1 | 1 |
| LA 473 | WM 1948 | Colombia | CLIN | A | alpha | VNI |
| 1 | 1 | 1 | 1 |
| H99 | WM 846 | USA | CLIN | A | alpha | VNI |
| - | - | - | - |
| JG-02 | WM 2529 | USA | CLIN | - | alpha | VNII | This study | 5 | 5 | 5 | 5 |
| M27053 | WM 2577 | South Africa | CLIN | A | alpha | VNII | This study | 4 | 4 | 3 | 18 |
| PR-101 | WM 1352 | India | CLIN | - | alpha | VNII | This study | 6 | 5 | 5 | 19 |
| UON 11536 | WM 1462 | South Africa | CLIN | - | alpha | VNII | This study | 6 | 5 | 5 | 5 |
| WM626R | WM 626 | Australia | CLIN | A | alpha | VNII |
| 6 | 7 | 5 | 6 |
| Hamden C3-1 | WM 1408 | Brazil | ENV | A | alpha | VNII |
| 7 | 21 | 4 | 3 |
| RV 58146 | WM 1412 | Zaire | ENV | A | alpha | VNII |
| 5 | 6 | 5 | 4 |
| LA 146 | WM 553 | Brazil | ENV | A | alpha | VNII |
| 6 | 5 | 5 | 5 |
| LA 404 | WM 1816 | Mexico | CLIN | A | alpha | VNII |
| 6 | 5 | 5 | 5 |
| LA 511 | WM 1986 | Colombia | CLIN | A | alpha | VNII |
| 7 | 21 | 4 | 3 |
| bt1 | Botswana | CLIN | - | - | VNB |
| - | - | - | - | |
| bt22 | Botswana | CLIN | - | - | VNB |
| - | - | - | - | |
| bt31 | Botswana | CLIN | - | - | VNB |
| - | - | - | - | |
| bt131 | Botswana | CLIN | - | - | VNB |
| - | - | - | - | |
|
| |||||||||||
| WM 629R | WM 629 | Australia | CLIN | D | alpha | VNIV |
| 13 | 10 | 6 | 8 |
| RKI-M186/99 | WM 04.174 | Germany | CLIN | D | alpha | VNIV | This study | 9 | 11 | 17 | 7 |
| RKI-M318/90 | WM 04.172 | Germany | CLIN | D | alpha | VNIV | This study | 9 | 11 | 17 | 7 |
| B-3501 | WM 2242 | USA | CLIN | D | alpha | VNIV |
| 12 | 23 | 8 | 20 |
| CBS 7816 | Thailand | ENV | D | a | VNIV |
| 12 | 22 | 8 | 7 | |
| LA268 | WM 04.168 | Chile | CLIN | D | alpha | VNIV |
| 12 | 9 | 7 | 9 |
| JEC 20 | WM 01.126 | USA | NA | D | a | VNIV |
| 12 | 22 | 8 | 7 |
| JEC 21 | WM 01.127 | USA | NA | D | alpha | VNIV |
| 11 | 22 | 8 | 7 |
| KRIMM 2 | WM 02.142 | Russia | CLIN | - | alpha | VNIV | This study | 10 | 8 | 6 | 21 |
| LA262 | WM 1740 | Chile | CLIN | D | alpha | VNIV |
| 8 | 10 | 6 | 8 |
|
| |||||||||||
| LA1 | WM 1616 | Mexico | CLIN | B | alpha | VGI |
| 15 | 16 | 9 | 15 |
| 503 2738 | WM 1251 | Papua New Guinea | CLIN | B | alpha | VGI |
| 16 | 16 | 11 | 14 |
| WM 179R | WM 179 | Australia | CLIN | B | alpha | VGI |
| 15 | 17 | 9 | 14 |
| Joe | WM 1243 | Papua New Guinea | CLIN | B | alpha | VGI |
| 15 | 16 | 11 | 14 |
| MC-S-022 | WM 2634 | Thailand | CLIN | B | alpha | VGI |
| 17 | 31 | 23 | 16 |
| TP 0688 | WM 727 | USA | ENV | B | alpha | VGI | This study | 15 | 16 | 11 | 14 |
| TP 1414 | WM 2540 | New Zealand | VET | B | alpha | VGI | This study | 15 | 16 | 9 | 14 |
| LA175 | WM 1899 | Spain | CLIN | B | alpha | VGI |
| 14 | 19 | 24 | 15 |
| LA 564 | WM 2039 | Colombia | CLIN | B | alpha | VGI |
| 15 | 16 | 18 | 14 |
| F 2863 | WM 02.204 | Canada | VET | B | alpha | VGI |
| 14 | 18 | 25 | 24 |
| WM 1008 | WM 1008 | Australia | ENV | - | alpha | VGII |
| 20 | 12 | 13 | 12 |
| WM 178R | WM 178 | Australia | CLIN | B | alpha | VGII |
| 21 | 25 | 33 | 13 |
| MC-S-239 | WM 06.7 | Thailand | CLIN | B | alpha | VGII |
| 18 | 13 | 31 | 12 |
| RAM 002 | WM 03.27 | Australia | ENV | - | alpha | VGII |
| 19 | 12 | 13 | 12 |
| CBS 7750 | WM 06.13 | USA | ENV | B | alpha | VGII |
| 19 | 13 | 31 | 12 |
| LA 43 | WM 04.191 | Uruguay | ENV | B | alpha | VGII |
| 21 | 12 | 30 | 12 |
| LA 84 | WM 477 | Brazil | CLIN | - | alpha | VGII |
| 18 | 24 | 28 | 12 |
| CDC R369 | WM 02.46 | Canada | CLIN | B | alpha | VGII |
| 18 | 13 | 31 | 12 |
| NIH 444 | WM 02.81 | USA | CLIN | B | alpha | VGII |
| 18 | 13 | 31 | 12 |
| RB52 | WM 02.317 | Canada | ENV | B | alpha | VGII |
| 18 | 12 | 13 | 12 |
| AV 55 | WM 05.77 | Greece | CLIN | B | a | VGII |
| 21 | 14 | 14 | 12 |
| AV 54W | WM 05.75 | Greece | CLIN | B | alpha | VGII |
| 21 | 15 | 13 | 12 |
| AV 54S | WM 05.76 | Greece | CLIN | B | alpha | VGII |
| 21 | 15 | 13 | 12 |
| WM 175R | WM 175 | USA | ENV | B | alpha | VGIII |
| 22 | 26 | 26 | 11 |
| CN043 | WM 2423 | New Zealand | CLIN | - | a | VGIII |
| 23 | 29 | 19 | 22 |
| TP 0686 | WM 728 | USA | ENV | B | alpha | VGIII | This study | 22 | 26 | 26 | 11 |
| TP 0689 | WM 161 | USA | ENV | B | alpha | VGIII | This study | 22 | 28 | 26 | 11 |
| TP 0696 | WM 726 | USA | ENV | B | alpha | VGIII | This study | 22 | 26 | 26 | 11 |
| UCLA 380C | WM 1665 | USA | N | C | alpha | VGIII |
| 23 | 30 | 22 | 11 |
| LA 290 | WM 1699 | Paraguay | CLIN | - | alpha | VGIII |
| 23 | 30 | 10 | 11 |
| LA 382 | WM 1846 | Venezuela | CLIN | C | alpha | VGIII |
| 23 | 30 | 19 | 11 |
| LA 622 | WM 2176 | Colombia | CLIN | B | a | VGIII |
| 22 | 26 | 21 | 11 |
| LA 644 | WM 2158 | Colombia | ENV | C | alpha | VGIII |
| 23 | 30 | 19 | 11 |
| WM 779R | WM 779 | South Africa | VET | C | alpha | VGIV |
| 24 | 32 | 27 | 23 |
| B-5748 | WM 2364 | India | CLIN | B | alpha | VGIV | This study | 24 | 32 | 27 | 23 |
| B-5742 | WM 2363 | India | CLIN | B | alpha | VGIV | This study | 24 | 32 | 27 | 23 |
| M27055 | WM 04.20 | South Africa | CLIN | C | alpha | VGIV | This study | 24 | 32 | 12 | 23 |
| M27056 | WM 2579 | South Africa | CLIN | - | alpha | VGIV | This study | 24 | 32 | 12 | 23 |
| V00709 | WM 780 | South Africa | CLIN | C | alpha | VGIV | This study | 24 | 32 | 12 | 23 |
| V00869 | WM 2876 | South Africa | CLIN | C | alpha | VGIV | This study | 24 | 32 | 29 | 23 |
| LA 390 | WM 1802 | Mexico | CLIN | - | a | VGIV |
| 25 | 20 | 32 | 17 |
| LA 392 | WM 1804 | Mexico | CLIN | - | a | VGIV |
| 25 | 20 | 32 | 17 |
| LA 568 | WM 2041 | Colombia | CLIN | B | alpha | VGIV |
| 26 | 27 | 20 | 10 |
|
| |||||||||||
|
| |||||||||||
| CBS7841 | Canada | ENV | NA | NA | NA |
| - | - | - | - | |
|
| |||||||||||
| CBS142 | WM 773 | Japan | ENV | NA | NA | NA |
| - | - | - | - |
Geographic distribution and mating type data of all studied isolates.
| Molecular type | Continent | Total* | |||||
| Africa | Asia | Australia | Europe | North America | South America | ||
| VNI | 1 | 1 | 1 | 2 | 2 | 3 | 10 (0) |
| VNII | 3 | 1 | 1 | 0 | 1 | 4 | 10 (0) |
| VNIV | 0 | 1 (1) | 3 | 3 (1) | 2 | 10 (2) | |
| VGI | 0 | 1 | 4 | 1 | 2 | 2 | 10 (0) |
| VGII | 0 | 1 | 3 | 3 (1) | 4 | 2 | 13 (1) |
| VGIII | 0 | 0 | 1 (1) | 0 | 5 | 4 (1) | 10 (2) |
| VGIV | 5 | 2 | 0 | 0 | 0 | 3 (2) | 10 (2) |
|
|
|
|
|
|
|
|
|
Figure 1Mating type specific PCR amplification of the two mating type a VGIV strains LA390 and LA392.
A) primers MFαU and MFαL: MFa2U and MFa2L; B) primers SXI1αF and SXI1αR: SXI2aF and SXI2aR.
Figure 2Mating reaction on V8 media of the two mating type a VGIV strains.
A) LA390×NIH312; B) LA390×JF101; C) LA392×NIH312; D) LA392×JF101. All strains revealed typical bacilli-shape basidiospores and clamp connections (ac, bc, cc and dc).
Phylogenetic characters of the intron-excluded and intron-included data sets.
| Locus | Character (intron-excluded) | Character (intron-included) | substitution model | ||||
| total | constant | parsimony informative | total | constant | parsimony informative | ||
|
| 1124 | 848 | 177 | 1321 | 808 | 187 | GTR+G |
|
| 621 | 457 | 71 | 724 | 509 | 102 | SYM+G |
|
| 1877 | 1549 | 309 | 2265 | 1819 | 423 | HKY+G |
|
| 581 | 483 | 85 | 684 | 549 | 122 | K80+G |
|
| 4203 | 3337 | 564 | 4994 | 3685 | 834 | N/A |
Note: N/A = not applicable (partition of the dataset was used).
The second best model was chosen by the ModelTest program since the best (TrN+I and TrN+G) could not be operated in the MrBayes program due to the limitation of this software.
Figure 3Combined genealogies of (A) the intron-excluded and (B) the intron-included datasets with separate substitution models for each partition.
Parsimony bootstrap support above 75 is indicated in bold. Bayesian posterior probability above 95 is indicated italicized. The phylogenetic tree is rooted using Filobasidiella depauperata and Cryptococcus albidus as outgroups. The blue bold italic letters represent VNII-1 and VGIV-1 clades of C. neoformans and C. gattii, respectively.
Figure 4Gene genealogies of the four individual loci generated by Maximum Parsimony analysis.
Parsimony bootstrap support above 75 is indicated in bold. Bayesian posterior probability above 95 is indicated italicized. Phylogenetic trees are unrooted. The blue bold italic letters represent VNII-1 and VGIV-1 clades of C. neoformans and C. gattii, respectively.
Figure 5Variable sequence positions of all alignments of the VNII-1 and VGIV-1 strains revealed sequence similarity to VNI (ATCC90112 and WM148) and VGIII (WM175 and CN043) respectively.
However, some parts of the sequence were similar to that of VNII (WM626 and RV58146) for the VNII-1 strains and VGIV (WM779 and M27056) for the VGIV-1 strains. Black thick arrows reveal one of the cutting sites for URA5 RFLP giving VNII and VGIV patterns for the VNII-1 and VGIV-1 strains respectively.
Sequence similarity matrix among the haploid molecular type clades of the Cryptococcus species complex.
| VNI | VNII | VNII-1 |
| VNIV | VGI | VGII | VGIII | VGIV | VGIV-1 |
| |
| VNI |
|
|
|
|
|
|
|
|
|
| |
| VNII | 98.98 |
|
|
|
|
|
|
|
|
| |
| VNII-1 | 99.41 | 98.91 |
|
|
|
|
|
|
|
| |
|
| 99.11 | 99.63 | 99.16 |
|
|
|
|
|
|
| |
| VNIV | 94.74 | 94.71 | 94.68 | 94.7 |
|
|
|
|
|
| |
| VGI | 90.92 | 90.81 | 90.72 | 90.78 | 91.16 |
|
|
|
|
| |
| VGII | 91.37 | 91.22 | 91.23 | 91.23 | 91.68 | 97.28 |
|
|
|
| |
| VGIII | 91.18 | 91.15 | 91.00 | 91.11 | 91.40 | 98.07 | 97.40 |
|
|
| |
| VGIV | 91.02 | 90.82 | 90.82 | 90.82 | 91.22 | 97.21 | 97.20 | 97.32 |
|
| |
| VGIV-1 | 90.91 | 90.84 | 90.73 | 90.81 | 91.13 | 97.75 | 97.16 | 98.87 | 97.06 |
| |
|
| 90.99 | 90.82 | 90.80 | 90.82 | 91.2 | 97.37 | 97.19 | 97.79 | 99.11 | 97.76 |
= VNII+VNII-1; = VGIV+VGIV-1; numbers in italics designated values of standard errors.
Multilocus linkage disequilibrium analyses in each of the haploid molecular types of the Cryptococcus species complex.
| Population | No. of isolates | No. of haplotypes | All isolates | Haplotypes only | ||||
| IA | rBarD | PhI | IA | rBarD | PhI | |||
| VNI | 10 | 8 | 0.1595 | 0.0535 | 1 | 0.0551 | 0.0185 | 1 |
| VNII | 10 | 7 | 1.5655 | 0.5307 | 1 | 0.8809 | 0.3257 | 1 |
| VNIV | 10 | 8 | 1.0722 | 0.3643 | 1 | 0.6535 | 0.018 | 1 |
| VGI | 10 | 9 | 1.0818 | 0.3692 | 1 | 0.9189 | 0.3151 | 1 |
| VGII | 13 | 10 | 0.4573 | 0.1538 | 0.6666 | 0.1194 | 0.0399 | 0.6666 |
| VGIII | 10 | 7 | 0.9015 | 0.3038 | 1 | 0.4605 | 0.16059 | 1 |
| VGIV | 10 | 5 | 2.2432 | 0.7641 | 1 | 2 | 1 | 1 |
Note: PhI, Phylogenetic incompatibility.
P<0.05.
P<0.01.
P<0.001
Percent similarity representing the genetic variation among the haploid molecular types of the Cryptococcus species complex.
| Locus |
|
|
|
| |||||
| Total Characters |
|
|
|
| |||||
| Constant Characters | %Total | %PUI | %Total | %PUI | %Total | %PUI | %Total | %PUI | |
|
| VNI | 99.72 | 99.72 | 99.81 | 99.81 | 99.68 | 99.79 | 99.66 | 100 |
| VNII | 100 | 100 | 99.43 | 100 | 100 | 100 | 98.97 | 100 | |
| VNII-1 | 100 | N/A | 100 | N/A | 99.99 | N/A | 100 | N/A | |
| VNIV | 99.25 | 99.53 | 99.24 | 99.24 | 99.84 | 99.89 | 98.80 | 99.48 | |
|
| VGI | 99.53 | 99.91 | 99.05 | 99.43 | 99.36 | 99.68 | 100 | 100 |
| VGII | 99.34 | 99.44 | 98.29 | 99.43 | 98.88 | 99.04 | 99.83 | 100 | |
| VGIII | 99.81 | 99.81 | 99.24 | 99.62 | 99.63 | 99.79 | 99.83 | 100 | |
| VGIV | 100 | 100 | 100 | 100 | 99.89 | 99.95 | 100 | 100 | |
| VGIV-1 | 99.99 | N/A | 99.99 | N/A | 99.99 | N/A | 99.98 | N/A | |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
Note: The VNII-1 and VGIV-1 PI were excluded due to limitation of the PAUP program. (*Mean = mean of variable percentage of all original molecular types. ** C.s. complex = variable percentage calculated from the whole datasets. PUI = parsimony un-informative. N/A = not applicable).
Number of polymorphic sites of the intron-excluded combined dataset among different clades of the Cryptococcus species complex.
| Species and clades | Molecular type* | No. of polymorphic characters | No. of parsimony informative characters |
|
| 255 | 233 | |
|
| 73 | 57 | |
| VNI | 12 | 7 | |
| VNII | 9 | 0 | |
|
| VNIV | 22 | 14 |
|
| 236 | 201 | |
|
| 181 | 153 | |
| VGI | 24 | 10 | |
| VGIII | 14 | 8 | |
| VGIV | 2 | 1 | |
|
| VGII | 38 | 27 |
Notes: *VNII-1 and VGIV-1 were excluded. Genetic diversity (polymorphic characters) of C. gattii and C. neoformans is comparable (P<0.376). More genetic variation in the VGI+VGIII+VGIV and VGII clades, compared to the C.n. var. grubii (P<0.001) and C.n. var. neoformans clades (P<0.038), was observed.
Genetic distance and estimates of the times since divergence among gene lineages of the Cryptococcus species complex.
| Between taxon/major molecular type group | Node | Genes | Time since divergence in million years (95% confidence interval) | ||||
|
|
|
|
| Averages | |||
|
| a | 0.0399 | 0.1042 | 0.1315 | 0.0910 | 0.0980 (0.0890–0.1071) | 49.0 (44.5–53.5) |
|
| b | 0.0132 | 0.0426 | 0.0705 | 0.0506 | 0.0490 (0.0401–0.0579) | 24.5 (20.0–28.9) |
| VNI – VNII* | d | 0.0058 | 0.0088 | 0.0089 | 0.0185 | 0.0094 (0.0076–0.0113) | 4.7 (3.8–5.7) |
| VGI – VGIII* | f | 0.0083 | 0.0071 | 0.0262 | 0.0129 | 0.0171 (0.0133–0.0209) | 8.5 (6.7–10.4) |
| VGI,VGIII – VGIV* | e | 0.0145 | 0.0447 | 0.0262 | 0.0117 | 0.0235 (0.0196–0.0273) | 11.7 (9.8–13.6) |
| VGI,VGIII,VGIV – VGII* | c | 0.0099 | 0.0296 | 0.0326 | 0.0242 | 0.0221 (0.0221–0.0280) | 12.5 (11.1–14.0) |
Notes: * VNII-1 and VNIV-1 was not included in this calculation due to ambiguous placements in the molecular type lineages.
weighted averages of the genetic distance of all genes combined.
Figure 6Genealogy of the intron-excluded combined dataset revealed the time since divergence among lineages of the Cryptococcus species complex.
The number stated beside each node represents the ages of divergence in million years. Unlabelled branches are corresponding to VGIV-1 or VNII-1 groups, respectively.
Figure 7Genealogy of the combined dataset (PLB1, URA5, GPD1, IGS1) showing that the VNII-1 group isolates cluster with the VNB isolates previously described [15].
List of primers used in this study.
| Primers names | Primers sequences | Note | Source |
| CNACT1 |
| Amplify | This study |
| CNACT1R |
| Amplify | This study |
| CNACT1F2 |
| Internal primers of | This study |
| URA5 |
| Amplify |
|
| SJ101 |
| Amplify |
|
| PLBCNAF |
| Amplify | This study |
| PLBCNAR |
| Amplify | This study |
| PLBCG2F |
| Amplify | This study |
| PLBCG2R2 |
| Amplify | This study |
| PLBCNIF1 |
| Internal primers of | This study |
| PLBCNIF2 |
| Internal primers of | This study |
| PLBCNIR1 |
| Internal primers of | This study |
| IDEF |
| Amplify |
|
| IDER |
| Amplify |
|
| ACT1CAF1 |
| Amplify | This study |
| ACT1CAR1 |
| Amplify | This study |
| ACT1CAR2 |
| Amplify | This study |
| URA5DF1 |
| Amplify | This study |
| MFLL |
| Mating type α determination of VN |
|
| MFLR |
| Mating type α determination of VN |
|
| MFAL |
| Mating type a determination of VN |
|
| MFAR |
| Mating type a determination of VN |
|
| MFαU |
| Mating type α determination of VG |
|
| MFαL |
| Mating type α determination of VG |
|
| MFa2U |
| Mating type a determination of VG |
|
| MFa2L |
| Mating type a determination of VG |
|
| SXI1αF |
| Mating type α determination of VGIV |
|
| SXI1αR |
| Mating type α determination of VGIV |
|
| SXI2aF |
| Mating type a determination of VGIV |
|
| SXI2aR |
| Mating type a determination of VGIV |
|
| GPD1F |
| Amplify |
|
| GPD1R |
| Amplify |
|
| IGS1F |
| Amplify |
|
| IGS1R |
| Amplify |
|
Notes: VN = molecular type VNI, VNII and VNIV; VG = molecular type VGI, VGII, VGIII and IV, FD = Filobasidiella depauperata, CA = Cryptococcus albidus.